FR2352548A2 - Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation - Google Patents

Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation

Info

Publication number
FR2352548A2
FR2352548A2 FR7615815A FR7615815A FR2352548A2 FR 2352548 A2 FR2352548 A2 FR 2352548A2 FR 7615815 A FR7615815 A FR 7615815A FR 7615815 A FR7615815 A FR 7615815A FR 2352548 A2 FR2352548 A2 FR 2352548A2
Authority
FR
France
Prior art keywords
vitamin
trace element
animals
esp
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7615815A
Other languages
French (fr)
Other versions
FR2352548B2 (en
Inventor
Michel Lamand
Claudine Lab
Remy Roux
Paul Chagnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Priority to FR7615815A priority Critical patent/FR2352548A2/en
Publication of FR2352548A2 publication Critical patent/FR2352548A2/en
Application granted granted Critical
Publication of FR2352548B2 publication Critical patent/FR2352548B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Injectable compositions containing a suspension of trace elements insoluble in water, which are non-ionisable, and which are liberated slowly after intramuscular or subcutaneous injection by a moderated inflammatory process, esp. the free metals or their oxides, contain in addition an effective quantity of vitamin E (di - alpha - tocopheryl acetate). Used in treatment of disorders caused by trace element deficiency. Similar injections without vitamin E cause a painful inflammatory reaction esp. in cattle. The vitamin E prevents this. Typically the compositions contain metallic iron or manganese. In an example a composition contained 1000 mg metallic iron, particle size 44 microns, 3g tocopherol acetate, and purified olive oil to 10 ml. The dosage for 75-80 kg calves was 10 ml, and the animals showed no inflammation.
FR7615815A 1976-05-25 1976-05-25 Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation Granted FR2352548A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7615815A FR2352548A2 (en) 1976-05-25 1976-05-25 Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7615815A FR2352548A2 (en) 1976-05-25 1976-05-25 Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation

Publications (2)

Publication Number Publication Date
FR2352548A2 true FR2352548A2 (en) 1977-12-23
FR2352548B2 FR2352548B2 (en) 1978-10-20

Family

ID=9173620

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7615815A Granted FR2352548A2 (en) 1976-05-25 1976-05-25 Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation

Country Status (1)

Country Link
FR (1) FR2352548A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000038A1 (en) * 1996-07-02 1998-01-08 The Procter & Gamble Company Vitamin suspension
US6352730B1 (en) * 1997-07-02 2002-03-05 The Procter & Gamble Co. Suspension for adding a controlled amount of ingredient to a food product

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000038A1 (en) * 1996-07-02 1998-01-08 The Procter & Gamble Company Vitamin suspension
EP0917432A1 (en) * 1996-07-02 1999-05-26 The Procter & Gamble Company Vitamin suspension
CN1082350C (en) * 1996-07-02 2002-04-10 普罗克特和甘保尔公司 Vitamin suspension
US6352730B1 (en) * 1997-07-02 2002-03-05 The Procter & Gamble Co. Suspension for adding a controlled amount of ingredient to a food product

Also Published As

Publication number Publication date
FR2352548B2 (en) 1978-10-20

Similar Documents

Publication Publication Date Title
DE3260474D1 (en) Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
ES376594A1 (en) Cosmetic compositions
ATE271614T1 (en) QUINONE DERIVATIVES TO IMPROVE CELLULAR BIOENERGY
GB1102979A (en) Improvements in or relating to pellets for supplying biologically active substances to ruminants
ES8608540A1 (en) Novel growth hormone-releasing peptides and method of treating mammals therewith.
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES8206448A1 (en) Insulin analogues.
FR2352548A2 (en) Trace element suspensions for injection into animals - contg. vitamin=E to prevent inflammation
ES2174838T3 (en) METHOD TO INCREASE THE INTESTINE ABSORPTION.
STOUFFER et al. Reversible binding of ACTH to a glass surface
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
JPS5342199A (en) Production of globular titania
GB1245044A (en) Improvements in anti-microbial compositions
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
PT77593A (en) Method of treating 2-alpha-cyano-4-alpha 5-alpha-epoxy-3-oxo-steroid compounds and a process for the preparation of pharmaceu-tical compositions containing the same with a controlled particle size
DE2357507C3 (en) Means to increase fertility
ES449874A1 (en) Compound for the treatment of bovine mastitis
JPS57169425A (en) Composition and method for preventing adsorption of secretin
DD254881A1 (en) NON-PARENTERAL APPLICABLE INSULIN PREPARATION WITH DELAYED EFFECT
Quarterman et al. Effect of short fasts on heavy metal absorption in the rat
RU93009875A (en) Poultry Feed Additive
GB1315275A (en) Insecticide
UA18708A (en) Method for acid treatment of bed
JPS5231820A (en) Preparation of injections
IL64744A (en) Complexing agents containing urea and carboxylic acids,methods for complexing metals using them,metal complexes formed therewith and plant nutrient,pharmaceutical and veterinary compositions containing said complexes